News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Facet Biotech Chief Business Officer “Terminated”
January 7, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
January 6, 2009 - San Francisco Business Times - Redwood City’s Facet Biotech Corp. — recently spun off from PDL BioPharma Inc. — will part with its chief business officer Friday.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Layoff Tracker
Shortly after Vertex acquisition, Crinetics will cut 78 employees
November 9, 2026
·
120 min read
·
BioSpace Editorial Staff
Earnings
Moderna enjoys stable vaccine sales thanks to global COVID uptake
November 6, 2026
·
4 min read
·
Annalee Armstrong
Manufacturing
Forge’s Piteri-Molina on AI, Ohio and what’s next for gene therapy manufacturing
November 6, 2026
·
4 min read
·
Gabrielle Masson
Layoffs
Agios axes 100-plus R&D roles while awaiting FDA decision
November 6, 2026
·
2 min read
·
Gabrielle Masson
